These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21169250)

  • 1. Biologically targeted cancer therapy and marginal benefits: are we making too much of too little or are we achieving too little by giving too much?
    Fojo T; Parkinson DR
    Clin Cancer Res; 2010 Dec; 16(24):5972-80. PubMed ID: 21169250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities and obstacles to combination targeted therapy in renal cell cancer.
    Sosman JA; Puzanov I; Atkins MB
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):764s-769s. PubMed ID: 17255307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy for thyroid cancer: An updated review of investigational agents.
    Deshpande HA; Gettinger SN; Sosa JA
    Curr Opin Investig Drugs; 2010 Jun; 11(6):661-8. PubMed ID: 20496261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular toxicity of targeted therapies.
    Renouf DJ; Velazquez-Martin JP; Simpson R; Siu LL; Bedard PL
    J Clin Oncol; 2012 Sep; 30(26):3277-86. PubMed ID: 22649132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug development for cancer chemoprevention: focus on molecular targets.
    Johnson KA; Brown PH
    Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making the investigational oncology pipeline more efficient and effective: are we headed in the right direction?
    LoRusso PM; Anderson AB; Boerner SA; Averbuch SD
    Clin Cancer Res; 2010 Dec; 16(24):5956-62. PubMed ID: 21169248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.
    Meyers FJ; Linder J; Beckett L; Christensen S; Blais J; Gandara DR
    J Pain Symptom Manage; 2004 Dec; 28(6):548-56. PubMed ID: 15589080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards novel paradigms for cancer therapy.
    Pavet V; Portal MM; Moulin JC; Herbrecht R; Gronemeyer H
    Oncogene; 2011 Jan; 30(1):1-20. PubMed ID: 20935674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating clinical trials into meaningful outcomes.
    LoRusso PM; Schnipper LE; Stewart DJ; Boerner SA; Averbuch SD; Wolf W
    Clin Cancer Res; 2010 Dec; 16(24):5951-5. PubMed ID: 21169247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DrugPath: a database for academic investigators to match oncology molecular targets with drugs in development.
    Shah ED; Fisch BM; Arceci RJ; Buckley JD; Reaman GH; Sorensen PH; Triche TJ; Reynolds CP
    Cancer Chemother Pharmacol; 2014 May; 73(5):1089-93. PubMed ID: 24663501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecularly targeted therapy for malignant glioma.
    Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
    Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of bone metastases and the benefits of bone-targeted therapy.
    Lipton A
    Semin Oncol; 2010 Oct; 37 Suppl 2():S15-29. PubMed ID: 21111244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.